Delivery Order 36C10G22D0004-36C10G26N0028
- Not listed
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Tempus AI, Inc. (doing business as Tempus Labs Inc.) for tumor normal matched genomic testing services. The contract has a ceiling value of $325,119.50 and a performance period through September 25, 2023. Tempus Labs is a technology company specializing in precision medicine and genomic sequencing services. This contract supports the VA's precision oncology initiatives for veteran cancer...
- This federal contract award to Tempus AI, Inc. (doing business as Tempus Labs Inc.) is for tumor normal matched genomic testing services for the U.S. Department of Veterans Affairs (VA). The $5,718,045.00 firm fixed price delivery order contract, awarded on January 28, 2025, has a performance period extending through January 27, 2027. Tempus Labs Inc. is an experienced provider of genomic sequencing and precision medicine services to the VA, holding a larger $64,296,441.00 Indefinite Delivery...
- Tempus Labs Inc. is providing tumor normal matched genomic testing services to the Department of Veterans Affairs (VA) under a $5,999,647 firm fixed price delivery order. This order was issued against an Indefinite Delivery contract held by Tempus with the VA worth up to $64 million for such services. Through January 2027, Tempus will analyze genomic sequencing data from veteran cancer patients' tumor and normal tissue samples to help inform precision medicine treatment decisions within the VA...
- This federal contract award is for TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES, awarded by the U.S. Department of Veterans Affairs (VA) to Tempus AI, Inc., doing business as Tempus Labs Inc. The contract has a ceiling value of $7,989,504.00 and is a firm fixed price delivery order with a performance period through January 27, 2024. Tempus Labs Inc. is the prime contractor and specializes in precision medicine and genomic sequencing services. The company has established itself as a key provider...
- The Department of Veterans Affairs (VA) awarded a $2,022,406 Firm Fixed Price Delivery Order contract to Tempus Labs Inc., doing business as Tempus, to provide Tumor Normal Matched Genomic Testing Services. Tempus will perform genomic testing services on tumor and normal tissue samples from VA patients to identify genomic variants that may be targeted for precision cancer therapies. The contract has a one-year period of performance starting January 28, 2022 through January 27, 2023 and will be...
- This is a firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters (VA HQ) to Akesogen, Inc.'s Tempus Labs division. The contract, valued at $10,477,738.83, tasks Tempus Labs with providing genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services in support of the VA's biomedical research programs. The work is performed at the VA HQ in Washington, D.C. with...
- The Department of Veterans Affairs Headquarters awarded Akesogen, Inc. Tempus Labs, Inc. Division, a for-profit organization, a Firm Fixed Price Delivery Order contract worth $9,874,980.00 to provide genomic analysis services. The contract, with a performance period ending March 20, 2024, tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services at the VA Headquarters in...
- This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...
- This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Tempus AI, Inc. (Tempus Labs Inc.) to provide DNA methylation and genome-wide association services to evaluate changes in epigenetic aging for veterans with HIV who participated in a telehealth-delivered high-intensity exercise study. The contract has a ceiling value of $67,572.00 and a period of performance through September 29, 2025. There is no set-aside designation for this requirement....
- The Department of Veterans Affairs (VA) Headquarters awarded a firm fixed price delivery order contract to Akesogen, Inc.'s Tempus Labs, Inc. division, a for-profit technology company that provides genomic sequencing and analysis services. The $13,020,379.40 contract tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services to support the VA's biomedical research programs,...
- 36C10G22D0004Indefinite Delivery Contract
- 36C10G22D0004-36C10G26N0028Delivery Order
This modification P9 updates a single-award Indefinite Delivery Contract (IDC) valued at $64.3 million that was originally awarded to Tempus AI, Inc. (doing business as Tempus Labs Inc.) on January 28, 2022, with an ultimate completion date of January 27, 2027. The modification changes the contracting officer and adds Veterans Affairs Acquisition Regulation (VAAR) clause 852.222-71 regarding compliance with Executive Order 13899. The contract represents a civilian agency award with no set-aside designation and involves firm fixed price delivery orders for tumor normal matched genomic testing services performed at Tempus's facilities in Fredericksburg, Virginia and Chicago, Illinois. Prior delivery orders under this IDC have ranged from approximately $325,000 to $8.0 million, supporting the Department of Veterans Affairs' precision oncology initiatives. Tempus AI, a Chicago-based precision medicine company specializing in advanced genomic sequencing and analysis, has established itself as a key federal technology provider, particularly through its extensive contract portfolio with the VA. The company delivers comprehensive genomic profiling services including DNA methylation analysis, genome-wide association studies, and tumor profiling to support personalized cancer treatment strategies for veteran patients. This contract modification maintains the firm fixed price structure and enables the VA to continue issuing delivery orders for specialized genomic testing services that inform precision medicine initiatives across the agency's healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3m | 1/27/26 |